戻る Agenda
Track 1 Session 1 : An Overview of Patient Centric Industry PV Practice
Session Chair(s)
Prashant Joshi, RPh
Executive Director - Drug Safety
Fortrea, India
Patients’ safety is the corner stone of all safety surveillance activities performed by the healthcare industry. This session provides a deeper insight into some of the frequently performed activities such as PSP and how does Industry manage Medico Legal cases. Industry also looks forward to guidelines provided by groups comprising of Global PV Experts such as CIOMS Working Group. This session shall highlight the latest guidance from CIOMS Working Group XII on ‘Risk Benefit Assessment’.
Speaker(s)
CIOMS Working Group XII Report on “Risk Benefit Approach”
E. Stewart Geary, MD
Eisai Co., Ltd., Japan
MD, Global Safety Officer
Management of Medico Legal Cases – East vs West
Mangesh Kulkarni, MD
Tata Consultancy Services, India
Global Head – Drug Safety
Real World Evidence Through Patient Support Programs – An Industry Approach. Challenges & Pragmatic Approaches
Vinod Mattoo
DiagnoSearch Life Sciences, India
Executive Director